IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Revolution Medicines Inc

CUSIP: 76155XAA8 | 47 institutional holders

Quarters

Q3 2026Q2 2026
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q3 2026

Mackay Shields LLC48,743,000
2.3% of portfolio›$62.8M
Calamos Advisors LLC32,030,000
0.1% of portfolio›$41.3M
Context Capital Management, LLC3,000,000
0.1% of portfolio›$3.9M
AGF Management LTD1,000,000
0.0% of portfolio›$1.3M
RWC Asset Management LLP770,000
0.0% of portfolio›$992.7K
Calamos Wealth Management LLC585,000
0.0% of portfolio›$754.9K
Central Pacific Bank - Trust Division354,000
0.0% of portfolio›$454.5K
Bank of New York Mellon Corp250,000
0.0% of portfolio›$322.3K
Oppenheimer Asset Management Inc.196,000
0.0% of portfolio›$251.6K
StyleTurnoverLocationFiled
Mackay Shields LLC
48,743,000$62.8M2.3%Deep ValueLowNew York, NY2026-10-13
Calamos Advisors LLC
32,030,000$41.3M0.1%GrowthMediumNaperville, IL2026-11-02
Context Capital Management, LLC
3,000,000$3.9M0.1%GARPHighGreenwich, CT2026-11-04
AGF Management LTD
1,000,000$1.3M0.0%GrowthHighToronto, Australia2026-11-03
RWC Asset Management LLP
770,000$992.7K0.0%YieldMediumLondon, United Kingdom2026-10-22
Calamos Wealth Management LLC
585,000$754.9K0.0%GrowthMediumNaperville, IL2026-11-02
Central Pacific Bank - Trust Division
354,000$454.5K0.0%CoreMediumHonolulu, HI2026-10-06
Bank of New York Mellon Corp
250,000$322.3K0.0%CoreLowNew York, NY2026-11-05
Oppenheimer Asset Management Inc.
196,000$251.6K0.0%CoreMediumNew York, NY2026-10-27